Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Principal Technologies ( (TSE:PTEC) ) has shared an update.
Principal Technologies has entered into a research and development agreement with the University of Oxford to develop a thermal sensor for medical applications, including cancer diagnosis and treatment. Additionally, the company is divesting its majority stake in its Austrian subsidiary, E&E CRO Consulting GmbH, to focus more on its own R&D activities, while maintaining a minority interest in the subsidiary.
More about Principal Technologies
Principal Technologies Inc. is a global healthcare technologies investor focused on building a portfolio of profitable healthcare technology companies. The company emphasizes global distribution potential and intellectual property that enhances medical treatment quality, cost efficiency, patient pathway optimization, and point of care technologies.
Average Trading Volume: 25,135
Technical Sentiment Signal: Buy
Current Market Cap: C$12.11M
For detailed information about PTEC stock, go to TipRanks’ Stock Analysis page.